Issue 3/2005
Content (13 Articles)
Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
Ronald de Wit, Matti Aapro, Peter R Blower
Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models
Christopher M. K. Springate, John K. Jackson, Martin E. Gleave, Helen M. Burt
P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing
Daniel L. Gustafson, Michael E. Long, Erica L. Bradshaw, Andrea L. Merz, Patrick J. Kerzic
Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent
Hui Wang, Zhi Wang, Shuyi Wang, Mao Li, Li Nan, Julie K. Rhie, Joseph M. Covey, Ruiwen Zhang, Donald L. Hill
Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives
Panagiota Papazafiri, Nicolaos Avlonitis, Panagiotis Angelou, Theodora Calogeropoulou, Maria Koufaki, Efi Scoulica, Irene Fragiadaki
Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma
Sung-Shin Park, Yong-Nyun Kim, Yoon Kyung Jeon, Young A Kim, Ji Eun Kim, Heejung Kim, Chul Woo Kim
In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines
Risa Tanaka, Yasushi Takii, Yoshihiro Shibata, Hiroshi Ariyama, Baoli Qin, Eishi Baba, Hitoshi Kusaba, Kenji Mitsugi, Mine Harada, Shuji Nakano
Potential for drug interactions in hospitalized cancer patients
Rachel Pimenta Riechelmann, Frederico Moreira, Òren Smaletz, Everardo D. Saad
Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents
Hui Wang, Mao Li, Julie K. Rhie, David M. Hockenbery, Joseph M. Covey, Ruiwen Zhang, Donald L. Hill
Metabolism of docetaxel in mice
Heleen A. Bardelmeijer, Arjan B. G. H. Roelofs, Michel J. X. Hillebrand, Jos H. Beijnen, Jan H. M. Schellens, Olaf van Tellingen
Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo
Tyler Digby, Marsha K. Leith, James A. Thliveris, Asher Begleiter
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma
Kevin T. Murphy, Abdullah Wardak, Michael A. Beckett, Carlos A. Lopez, Neil Mehta, Eric Kimchi, Rabih M. Salloum, Nora T Jaskowiak, Mitchell C. Posner, Tsuneya Ohno, Donald W. Kufe, Ralph R. Weichselbaum, Helena J. Mauceri
Effects and interaction of 7-hydroxy methotrexate and methotrexate in leukaemic cells ex vivo measured by the thymidylate synthase inhibition assay
R. M. Lingg, G. Hempel, M. G. Rots, C. H. Van Zantwijk, J. Boos, G. J. L. Kaspers